Isabel Amador‐Martínez

403 total citations
16 papers, 291 citations indexed

About

Isabel Amador‐Martínez is a scholar working on Molecular Biology, Nephrology and Clinical Biochemistry. According to data from OpenAlex, Isabel Amador‐Martínez has authored 16 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Nephrology and 3 papers in Clinical Biochemistry. Recurrent topics in Isabel Amador‐Martínez's work include Genomics, phytochemicals, and oxidative stress (3 papers), Acute Kidney Injury Research (3 papers) and Mitochondrial Function and Pathology (2 papers). Isabel Amador‐Martínez is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (3 papers), Acute Kidney Injury Research (3 papers) and Mitochondrial Function and Pathology (2 papers). Isabel Amador‐Martínez collaborates with scholars based in Mexico, France and United States. Isabel Amador‐Martínez's co-authors include Ana Karina Aranda‐Rivera, Alfredo Cruz‐Gregorio, José Pedraza-Chaverrı́, Estefani Yaquelin Hernández‐Cruz, Jonatan Barrera‐Chimal, Omar Emiliano Aparicio‐Trejo, Edilia Tapia, Laura Gabriela Sánchez‐Lozada, Rosalba Pérez‐Villalva and Norma Uribe and has published in prestigious journals such as SHILAP Revista de lepidopterología, The FASEB Journal and Free Radical Biology and Medicine.

In The Last Decade

Isabel Amador‐Martínez

15 papers receiving 291 citations

Peers

Isabel Amador‐Martínez
Isabel Amador‐Martínez
Citations per year, relative to Isabel Amador‐Martínez Isabel Amador‐Martínez (= 1×) peers Radana Gurecká

Countries citing papers authored by Isabel Amador‐Martínez

Since Specialization
Citations

This map shows the geographic impact of Isabel Amador‐Martínez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Amador‐Martínez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Amador‐Martínez more than expected).

Fields of papers citing papers by Isabel Amador‐Martínez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Amador‐Martínez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Amador‐Martínez. The network helps show where Isabel Amador‐Martínez may publish in the future.

Co-authorship network of co-authors of Isabel Amador‐Martínez

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Amador‐Martínez. A scholar is included among the top collaborators of Isabel Amador‐Martínez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Amador‐Martínez. Isabel Amador‐Martínez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Aranda‐Rivera, Ana Karina, Isabel Amador‐Martínez, Omar Emiliano Aparicio‐Trejo, et al.. (2025). Sulforaphane Restores Mitochondrial β-Oxidation and Reduces Renal Lipid Accumulation in a Model of Releasing Unilateral Ureteral Obstruction. Antioxidants. 14(3). 288–288.
2.
Amador‐Martínez, Isabel, Omar Emiliano Aparicio‐Trejo, Ana Karina Aranda‐Rivera, et al.. (2025). Effect of N-Acetylcysteine in Mitochondrial Function, Redox Signaling, and Sirtuin 3 Levels in the Heart During Cardiorenal Syndrome Type 4 Development. Antioxidants. 14(3). 367–367. 1 indexed citations
3.
Aranda‐Rivera, Ana Karina, Alfredo Cruz‐Gregorio, Isabel Amador‐Martínez, et al.. (2024). Antioxidants targeting mitochondria function in kidney diseases. SHILAP Revista de lepidopterología. 2. 21–37. 6 indexed citations
4.
Amador‐Martínez, Isabel, et al.. (2024). Role of mitochondria in reno-cardiac diseases: A study of bioenergetics, biogenesis, and GSH signaling in disease transition. Redox Biology. 76. 103340–103340. 18 indexed citations
5.
Aranda‐Rivera, Ana Karina, Isabel Amador‐Martínez, Omar Emiliano Aparicio‐Trejo, et al.. (2023). The Development of Dyslipidemia in Chronic Kidney Disease and Associated Cardiovascular Damage, and the Protective Effects of Curcuminoids. Foods. 12(5). 921–921. 14 indexed citations
6.
Amador‐Martínez, Isabel, Omar Emiliano Aparicio‐Trejo, Ana Karina Aranda‐Rivera, et al.. (2023). Mitochondrial Impairment: A Link for Inflammatory Responses Activation in the Cardiorenal Syndrome Type 4. International Journal of Molecular Sciences. 24(21). 15875–15875. 12 indexed citations
7.
Aranda‐Rivera, Ana Karina, Alfredo Cruz‐Gregorio, Isabel Amador‐Martínez, et al.. (2023). Sulforaphane protects from kidney damage during the release of unilateral ureteral obstruction (RUUO) by activating nuclear factor erythroid 2-related factor 2 (Nrf2): Role of antioxidant, anti-inflammatory, and antiapoptotic mechanisms. Free Radical Biology and Medicine. 212. 49–64. 9 indexed citations
8.
Orozco‐Ibarra, Marisol, Omar Emiliano Aparicio‐Trejo, Estefani Yaquelin Hernández‐Cruz, et al.. (2023). Assessment of Kidney Mitochondrial Function by High-Resolution Respirometry, Transmission Electron Microscopy, and Histological Techniques. Methods in molecular biology. 2664. 283–308. 2 indexed citations
9.
Cruz‐Gregorio, Alfredo, Ana Karina Aranda‐Rivera, Isabel Amador‐Martínez, & Paola Maycotte. (2023). Mitochondrial transplantation strategies in multifaceted induction of cancer cell death. Life Sciences. 332. 122098–122098. 21 indexed citations
10.
Aranda‐Rivera, Ana Karina, Alfredo Cruz‐Gregorio, Omar Emiliano Aparicio‐Trejo, et al.. (2022). Sulforaphane Protects against Unilateral Ureteral Obstruction-Induced Renal Damage in Rats by Alleviating Mitochondrial and Lipid Metabolism Impairment. Antioxidants. 11(10). 1854–1854. 31 indexed citations
11.
Hernández‐Cruz, Estefani Yaquelin, Isabel Amador‐Martínez, Ana Karina Aranda‐Rivera, Alfredo Cruz‐Gregorio, & José Pedraza-Chaverrı́. (2022). Renal damage induced by cadmium and its possible therapy by mitochondrial transplantation. Chemico-Biological Interactions. 361. 109961–109961. 72 indexed citations
12.
Amador‐Martínez, Isabel, Estefani Yaquelin Hernández‐Cruz, Laura Gabriela Sánchez‐Lozada, et al.. (2021). Mitochondrial Transplantation: Is It a Feasible Therapy to Prevent the Cardiorenal Side Effects of Cisplatin?. MDPI (MDPI AG). 1(1). 3–26. 9 indexed citations
13.
Amador‐Martínez, Isabel, et al.. (2021). Early inflammatory changes and CC chemokine ligand‐8 upregulation in the heart contribute to uremic cardiomyopathy. The FASEB Journal. 35(8). 9 indexed citations
14.
Tarjus, Antoine, Isabel Amador‐Martínez, Benjamin Bonnard, et al.. (2019). The Absence of Endothelial Sodium Channel α (αENaC) Reduces Renal Ischemia/Reperfusion Injury. International Journal of Molecular Sciences. 20(13). 3132–3132. 19 indexed citations
15.
Amador‐Martínez, Isabel, et al.. (2019). Reduced endothelial nitric oxide synthase activation contributes to cardiovascular injury during chronic kidney disease progression. American Journal of Physiology-Renal Physiology. 317(2). F275–F285. 25 indexed citations
16.
Barrera‐Chimal, Jonatan, Isabel Amador‐Martínez, Rosalba Pérez‐Villalva, et al.. (2018). Delayed spironolactone administration prevents the transition from acute kidney injury to chronic kidney disease through improving renal inflammation. Nephrology Dialysis Transplantation. 34(5). 794–801. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026